XLV vs IBB: How Healthcare Diversification Compares to Biotech Concentration
XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.